Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
Primary Purpose
Cardiovascular Diseases, Carotid Artery Diseases, Intracranial Arteriosclerosis
Status
Terminated
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Vitamin E
Vitamin C
Sponsored by
About this trial
This is an interventional prevention trial for Cardiovascular Diseases
Eligibility Criteria
Inclusion Criteria: African American
Sites / Locations
Outcomes
Primary Outcome Measures
rate of change in average common carotid artery intima-media thickness (measured over 24 months)
Secondary Outcome Measures
Full Information
NCT ID
NCT00000600
First Posted
October 27, 1999
Last Updated
December 12, 2013
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
1. Study Identification
Unique Protocol Identification Number
NCT00000600
Brief Title
Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
Official Title
Antioxidants and Prevention of Early Atherosclerosis
Study Type
Interventional
2. Study Status
Record Verification Date
October 2006
Overall Recruitment Status
Terminated
Study Start Date
June 1995 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
May 2000 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
4. Oversight
5. Study Description
Brief Summary
This study will evaluate the effects of vitamin E supplementation in retarding the progression of common carotid artery intima-media thickening in African Americans.
Detailed Description
BACKGROUND:
Evidence from epidemiologic studies, and from one unpublished study, suggests that greater intake of antioxidant vitamins is associated with reduced risk of coronary heart disease and stroke. Findings from an animal model indicate that increased intake of antioxidant vitamins prevents progression of aortic fatty streaks induced by an atherogenic diet, but not from more advanced injury-induced lesions. These observations suggest the hypothesis that increased antioxidant vitamin intake may prevent further progression of early atherosclerosis, possibly by means of reduced susceptibility of low density lipoprotein to oxidative modification and consequent cytotoxic, chemotactic, chemostatic, and unregulated uptake effects.
A new, automated, low-cost, portable ultrasound system for determining intima-media thickness of the common carotid artery makes it feasible to test the primary prevention impact of antioxidant vitamins on early atherosclerosis. Results of two studies at the University of Southern California suggest that the low-density lipoprotein effects on common carotid artery intima-media thickness can be detected by automated methods within 12 to 24 months in small patient samples. Retardation of intima-media thickness progression was achieved in both studies without significant changes in average vessel diameter, which suggests effects on early atherosclerotic lesions.
DESIGN NARRATIVE:
Patients will be screened for carotid intima-media thickness at home or at schools in mobile vans equipped with portable ultrasound equipment. After 12 months, those patients above the age and sex-adjusted 66th percentile at Screen I will be re-screened (Screen II), and those showing the greatest progression in intima-media thickness will be invited to participate in a trial run-in to assess vitamin E compliance. Patients will be randomized to the following four groups: 1) vitamin E (573 mg/day); 2) vitamin C; 3) Vitamin E and C combined; and 4) placebo. Common carotid artery intima-media thickness will be observed by ultrasound at 12- and 24-month follow-ups. The primary outcome is 24-month rate of change in average common carotid artery intima-media thickness.
The study completion date listed in this record was obtained from the Query/View/Report (QVR) System.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Diseases, Carotid Artery Diseases, Intracranial Arteriosclerosis, Cerebrovascular Disorders, Heart Diseases, Vascular Diseases, Atherosclerosis
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 2
Allocation
Randomized
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Vitamin E
Intervention Type
Drug
Intervention Name(s)
Vitamin C
Primary Outcome Measure Information:
Title
rate of change in average common carotid artery intima-media thickness (measured over 24 months)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
59 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
African American
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James H. Dwyer, III
Organizational Affiliation
University of Southern California
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
We'll reach out to this number within 24 hrs